Teva Pharmaceuticals USA, Inc.
Recent News About Teva Pharmaceuticals USA, Inc. View More
-
Federal court says $125 million antitrust settlement is valid and dismisses outside counsel's objections
PHILADELPHIA – A federal judge in Philadelphia recently ruled that a $125 million antitrust settlement concerning sleep disorder drug Provigil is valid, dismissing some lawyers' claims to the contrary. -
Lawrence County blames doctors and pharmaceutical companies for opioid crisis
NEW CASTLE — Lawrence County is suing several physicians and pharmaceutical companies, citing alleged violation of the Unfair Trade Practices and Consumer Protection Act, as well as fraud, unjust enrichment, negligence, negligent misrepresentation and causing a public nuisance. -
City of Philadelphia sues opioid manufacturers for alleged role in 'public health crisis'
PHILADELPHIA – The City of Philadelphia has become the latest government entity in the Commonwealth of Pennsylvania to sue opioid manufacturers for deceptive marketing practices and creating what it has termed “an unprecedented public health crisis.” -
Two defendants seek dismissal of Teva Pharmaceuticals trade secrets lawsuit
PHILADELPHIA – Two defendants named by Teva Pharmaceuticals USA Inc. in a July 7 Trade Secrets Act and Computer Fraud and Abuse Act lawsuit have asked the U.S. District Court for the Eastern District of Pennsylvania to dismiss the cases against them.